Chengdu huasun technology group Inc. , LTD. (SHE:000790)
3.490
0.00 (0.00%)
Apr 30, 2025, 3:04 PM CST
SHE:000790 Revenue
In the year 2024, Chengdu huasun technology group Inc. , LTD. had annual revenue of 863.98M CNY, down -13.89%. Chengdu huasun technology group Inc. , LTD. had revenue of 200.90M in the quarter ending December 31, 2024, a decrease of -39.29%.
Revenue
863.98M
Revenue Growth
-13.89%
P/S Ratio
2.68
Revenue / Employee
947.04K
Employees
857
Market Cap
2.18B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 863.98M | -139.40M | -13.89% |
Dec 31, 2023 | 1.00B | 130.27M | 14.92% |
Jan 1, 2023 | 873.10M | -81.58M | -8.55% |
Jan 1, 2022 | 954.69M | 195.38M | 25.73% |
Dec 31, 2020 | 759.31M | 13.97M | 1.87% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |